{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:36:08Z","timestamp":1791272168155,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1136\/ard.2006.061507","type":"journal-article","created":{"date-parts":[[2007,1,12]],"date-time":"2007-01-12T20:13:48Z","timestamp":1168632828000},"page":"1020-1025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis"],"prefix":"10.1016","volume":"66","author":[{"given":"Helmut","family":"Wittkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Foell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik af","family":"Klint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen De","family":"Rycke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip De","family":"Keyser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Frosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kristin","family":"Ulfgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2006.061507_bib1","doi-asserted-by":"crossref","first-page":"F47","DOI":"10.1084\/jem.193.12.F47","article-title":"On the role of the innate immunity in autoimmune disease","volume":"193","author":"Bachmann","year":"2001","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2006.061507_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","article-title":"Anti-TNF \u03b1 therapy of rheumatoid arthritis: what have we learned?","volume":"19","author":"Feldmann","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/ard.2006.061507_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/ard.2006.061507_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1471-4906(03)00062-0","article-title":"Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules","volume":"24","author":"Roth","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1136\/ard.2006.061507_bib5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"10.1136\/ard.2006.061507_bib6","doi-asserted-by":"crossref","first-page":"25291","DOI":"10.1074\/jbc.274.36.25291","article-title":"S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14","volume":"274","author":"Vogl","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2006.061507_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/gut.52.6.847","article-title":"Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease","volume":"52","author":"Foell","year":"2003","journal-title":"Gut"},{"key":"10.1136\/ard.2006.061507_bib8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.amjcard.2004.05.076","article-title":"Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease","volume":"94","author":"Ye","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1136\/ard.2006.061507_bib9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI200114002","article-title":"The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses","volume":"108","author":"Schmidt","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2006.061507_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1196\/annals.1338.063","article-title":"Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis","volume":"1043","author":"Kim","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1136\/ard.2006.061507_bib11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J Mol Med"},{"key":"10.1136\/ard.2006.061507_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0889-857X(05)70201-5","article-title":"The epidemiology of rheumatoid arthritis","volume":"27","author":"Gabriel","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.2006.061507_bib13","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/0952-7915(92)90057-L","article-title":"Cytokines in autoimmunity","volume":"4","author":"Brennan","year":"1992","journal-title":"Curr Opin Immunol"},{"key":"10.1136\/ard.2006.061507_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00920793","article-title":"Disease severity in rheumatoid arthritis: relationships of plasma tumour necrosis factor-\u03b1, soluble interleukin 2-receptor, soluble CD4\/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures","volume":"12","author":"Beckham","year":"1992","journal-title":"J Clin Immunol"},{"key":"10.1136\/ard.2006.061507_bib15","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","article-title":"Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-\u03b1 therapy in rheumatoid arthritis","volume":"163","author":"Charles","year":"1999","journal-title":"J Immunol"},{"key":"10.1136\/ard.2006.061507_bib16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","article-title":"Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor \u03b1 (cA2) versus placebo in rheumatoid arthritis","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"10.1136\/ard.2006.061507_bib17","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therapeutic efficacy of multiple intravenous infusions of anti-tumour necrosis factor \u03b1 monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis","volume":"41","author":"Maini","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061507_bib18","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor \u03b1 monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"10.1136\/ard.2006.061507_bib19","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumour Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2006.061507_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1081\/IPH-200067702","article-title":"Chimerical anti-TNF-\u03b1, infliximab, inhibits neutrophil chemotaxis and production of reactive oxygen species by blocking the priming effect of mononuclear cells on neutrophils","volume":"27","author":"Pay","year":"2005","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1136\/ard.2006.061507_bib21","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1053\/gast.2001.28702","article-title":"Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway","volume":"121","author":"Lugering","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1136\/ard.2006.061507_bib22","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/art.1780390702","article-title":"Decrease in cellularity and expression of adhesion molecules by anti-tumour necrosis factor \u03b1 monoclonal antibody treatment in patients with rheumatoid arthritis","volume":"39","author":"Tak","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061507_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/art.20764","article-title":"Evidence that anti-tumour necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report","volume":"52","author":"Catrina","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061507_bib24","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1002\/art.20631","article-title":"Proinflammatory S100 proteins in arthritis and autoimmune disease","volume":"50","author":"Foell","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.061507_bib25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/keg385","article-title":"Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis","volume":"42","author":"Foell","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2006.061507_bib26","first-page":"295","article-title":"A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process","volume":"55","author":"Zwadlo","year":"1987","journal-title":"Exp Cell Biol"},{"key":"10.1136\/ard.2006.061507_bib27","doi-asserted-by":"crossref","first-page":"R569","DOI":"10.1186\/ar1698","article-title":"Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis","volume":"7","author":"Kruithof","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2006.061507_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cccn.2004.02.023","article-title":"Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation","volume":"344","author":"Foell","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1136\/ard.2006.061507_bib29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nri1593","article-title":"Heat-shock proteins induce T-cell regulation of chronic inflammation","volume":"5","author":"van Eden","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/ard.2006.061507_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.it.2005.04.009","article-title":"HMGB1: guiding immunity from within","volume":"26","author":"Dumitriu","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1136\/ard.2006.061507_bib31","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2004-07-2520","article-title":"Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells","volume":"105","author":"Viemann","year":"2005","journal-title":"Blood"},{"key":"10.1136\/ard.2006.061507_bib32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/(SICI)1522-2683(20000201)21:3<665::AID-ELPS665>3.0.CO;2-U","article-title":"Calcium-dependent secretion in human neutrophils: a proteomic approach","volume":"21","author":"Boussac","year":"2000","journal-title":"Electrophoresis"},{"key":"10.1136\/ard.2006.061507_bib33","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1189\/jlb.69.6.986","article-title":"Proinflammatory properties of the human S100 protein S100A12","volume":"69","author":"Yang","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1136\/ard.2006.061507_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.gene.6363861","article-title":"RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response","volume":"3","author":"Hofmann","year":"2002","journal-title":"Genes Immun"},{"key":"10.1136\/ard.2006.061507_bib35","first-page":"1691","article-title":"Polyarticular corticosteroid injection versus systemic administration in treatment of rheumatoid arthritis patients: a randomized controlled study","volume":"32","author":"Furtado","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2006.061507_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/path.1758","article-title":"Differential expression and response to anti-TNF\u03b1 treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis","volume":"206","author":"De Rycke","year":"2005","journal-title":"J Pathol"},{"key":"10.1136\/ard.2006.061507_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/ard.59.6.439","article-title":"Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment","volume":"59","author":"Ulfgren","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.061507_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/03009740500439159","article-title":"The role of chemokines in rheumatoid arthritis and osteoarthritis","volume":"34","author":"Vergunst","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2006.061507_bib39","doi-asserted-by":"crossref","first-page":"R250","DOI":"10.1186\/ar1477","article-title":"Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis","volume":"7","author":"Capsoni","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2006.061507_bib40","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.4049\/jimmunol.171.2.1009","article-title":"IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-\u03b1 and leukotriene B4","volume":"171","author":"Cannetti","year":"2003","journal-title":"J Immunol"},{"key":"10.1136\/ard.2006.061507_bib41","first-page":"232","article-title":"Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumour necrosis factor-\u03b1 monoclonal antibody in patients with rheumatoid arthritis","volume":"30","author":"Den Broeder","year":"2003","journal-title":"J Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724347119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724347119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2006.061507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T19:33:52Z","timestamp":1736105632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724347119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0003496724347119"],"URL":"https:\/\/doi.org\/10.1136\/ard.2006.061507","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2006.061507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Copyright 2007 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}